Compay is developing a proprietary form of sonodynamic therapy as a first-in-class, noninvasive drug-device combination to treat recurrent glioblastoma.
Unique PlaqueTec Liquid Biopsy System will be used to collect blood samples containing biomolecules localizing at or being released by coronary plaque.
Partnership aims to enhance InfoBionic’s AI algorithms and analytics capabilities to provide more personalized and predictive insights to patients, clinicians.
Patient-centric advancements, hospital-at-home care, and regulatory initiatives provide a glimpse into remote healthcare services’ dynamic development.
Owlstone Medical's Phase 2 clinical trial will assess the test's diagnostic performance and enable its optimization through testing protocol refinement.